[Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension]. 1980

R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011704 Pyelonephritis Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA. Necrotizing Pyelonephritis,Pyelonephritis, Acute Necrotizing,Pyelonephritides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols

Related Publications

R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
January 1979, Minerva nefrologica,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
January 1994, Polskie Archiwum Medycyny Wewnetrznej,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
January 1952, Archivio "E. Maragliano" di patologia e clinica,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
January 1981, Pharmatherapeutica,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
September 1988, Vrachebnoe delo,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
April 1979, British journal of clinical pharmacology,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
January 1979, British journal of clinical pharmacology,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
September 1987, The Medical clinics of North America,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
October 1954, Klinische Wochenschrift,
R Palla, and A Bionda, and F Carmassi, and R Giusti, and M Marchitiello
October 1983, The American journal of medicine,
Copied contents to your clipboard!